GDF - Medical Technology Development
Abstract
Guidance for Development of the Force - Medical Technology Development provides funds for promising candidate solutions that are selected for initial safety and effectiveness testing in animal studies and/or small scale human clinical trials regulated by the US Food and Drug Administration prior to licensing for human use. Research in this PE is designed to address the following: areas of interest to the Secretary of Defense regarding Wounded Warriors, capabilities identified through the Joint Capabilities Integration and Development System, and the strategy and initiatives described in the Quadrennial Defense Review. Program development and execution is peer-reviewed and fully coordinated with all of the Military Services, appropriate Defense Agencies or Activities and other federal agencies, to include the Department of Veterans Affairs, the Department of Health and Human Services, and the Department of Homeland Security. This coordination occurs through the planning and execution activities of the Joint Program Committees (JPCs), established for the Defense Health Program, Research Development Test and Evaluation (RDT&E) funding. Research supported by this PE includes polytrauma and blast injury, diagnosis and treatment of brain injury, environmental health and performance, physiological and psychological health, injury prevention and reduction, medical simulation and training, health informatics, and rehabilitation.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2014
- Source ID
- 373A_0603115HP_2_0130_PB_2014
Related Documents
- Root: Medical Technology Development
- Child Accomplishment: GDF – Medical Technology Development